Skip to content
All Sections
Subscribe Now
71°F
Saturday, July 27th 2024
e-Edition
Home Page
Close Menu
News
News
Crime and Public Safety
Investigative Reporting
Politics
Health
Environment
Business
Best Reviews
Housing
Jobs
Local News
Local News
Long Beach
Los Angeles
Los Angeles County
Sports
Sports
High School Sports
Chargers
Rams
Lakers
Clippers
Dodgers
Angels
College Sports
UCLA Sports
USC Sports
Long Beach State sports
Kings
Ducks
Olympics
Boxing/MMA
Soccer
Horse Racing
Things To Do
Things To Do
Restaurants Food and Drink
Movies
Music + Concerts
Theater
TV and Streaming
Home + Garden
Travel
Amusement Parks
Comics
Puzzles
Events
Obituaries
Obituaries
News Obituaries
Place an Obituary
Opinion
Opinion
Editorials
Opinion Columns
Commentary
Letters to the Editor
Editorial Board
Endorsements
The Grunion
The Grunion
News
Education
Sports
Things to Do
Opinion
E-Edition
Advertising
Contact Us
SCNG Premium
The T.E.A.
Subscribe
Press-Telegram Store
Log In
Logout
Close Menu
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Account Settings
Contact Us
Log Out
Spoof a user
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Search
Press Telegram
71°F
Saturday, July 27th 2024
e-Edition
News
Local News
Sports
Things to Do
Obituaries
Opinion
The T.E.A.
Trending:
Man killed in garage
Olympics: How to watch ð¥
Arrests in street vendor killing
Affordable housing coming to Midtown
Optum layoffs, closures
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neoleukin Therapeutics Inc
(NQ:
NLTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 18, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
3.460 (1)
Ask (Size)
3.590 (5)
Prev. Close
3.490
Today's Range
N/A - N/A
52wk Range
0.6100 - 4.140
Shares Outstanding
42,425,071
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split
December 14, 2023
From
Neoleukin Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 05, 2023
Via
Benzinga
Performance
More News
Read More
Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket
October 05, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
October 05, 2023
Via
InvestorPlace
Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split
September 22, 2023
From
Neoleukin Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
August 17, 2023
Via
Benzinga
NEOLEUKIN THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Neoleukin Therapeutics, Inc. - NLTX
July 25, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sculptor Capital Management Inc. (NYSE – SCU), Neoleukin Therapeutics, Inc. (Nasdaq - NLTX), Pardes Bioscience, Inc. (Nasdaq – PRDS), Great Ajax Corp. (NYSE – AJX)
July 24, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Neoleukin Therapeutics, Inc. (Nasdaq - NLTX), Pardes Bioscience, Inc. (Nasdaq – PRDS), Kaleyra, Inc. (NYSE – KLR), Great Ajax Corp. (NYSE – AJX)
July 18, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Neoleukin Therapeutics To Merge With Neurogene: Creates Biotech Firm Focused On Genetic Medicines For Neurological Diseases
July 18, 2023
Via
Benzinga
NLTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Neoleukin Therapeutics, Inc. Is Fair to Shareholders
July 18, 2023
From
Halper Sadeh LLC
Via
Business Wire
Neurogene and Neoleukin Announce Definitive Merger Agreement
July 18, 2023
From
Neoleukin Therapeutics, Inc.
Via
GlobeNewswire
US Stocks Turn Lower; S&P 500 Down 1%
March 09, 2023
Via
Benzinga
Why JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 09, 2023
Via
Benzinga
US Stocks Pare Gains; BJ's Wholesale Club Earnings Top Views
March 09, 2023
Via
Benzinga
Neoleukin Therapeutics Seeks Strategic Alternatives, To Layoff More In Round 2 Within 6 Months
March 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 09, 2023
Via
Benzinga
Why Cassava Sciences Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
March 09, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 09, 2023
Via
InvestorPlace
Neoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition
March 08, 2023
From
Neoleukin Therapeutics, Inc.
Via
GlobeNewswire
Neoleukin Therapeutics Presents Preclinical Data on NEO-TRA1 at American Society of Hematology (ASH) Annual Meeting
December 12, 2022
From
Neoleukin Therapeutics, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
November 16, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
Via
Benzinga
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
November 16, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close